Home / CONCORDBIO.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CONCORDBIO.NS make money? Does CONCORDBIO.NS have pricing power? What's the Earnings Whisper? Will CONCORDBIO.NS profit more as the business scales? What is CONCORDBIO.NS's management track record? Is CONCORDBIO.NS's current price justified?

Concord Biotech Limited

₹1339 +$2.70 (+0.20%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹1353.3

Day Range

₹1332₹1366.8

Year Range

₹987₹1615

Market Cap

140.08B

AVG Volume

171.54K

Trailing/Forward PE

51.03/31.45

PEG ratio

2.72

Dividend Yield

0.56%

Next Earnings Date

2026-11-18

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

CONCORDBIO.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	2.57B
26 Q4	3.26B
26 Q3	2.78B
26 Q2	2.47B
26 Q1	2.04B
25 Q4	4.3B
25 Q3	2.44B
25 Q2	3.1B
25 Q1	2.16B
24 Q4	3.19B

Net Income (INR) · Q

CONCORDBIO.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	585.26M
26 Q4	887.9M
26 Q3	644.77M
26 Q2	630.63M
26 Q1	440.58M
25 Q4	1.4B
25 Q3	759.21M
25 Q2	957.41M
25 Q1	595.93M
24 Q4	950.16M

Operating Income (INR) · Q

CONCORDBIO.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	642.76M
26 Q4	989.88M
26 Q3	802.34M
26 Q2	701M
26 Q1	915.1M
25 Q4	1.92B
25 Q3	1.31B
25 Q2	2B
25 Q1	1.36B
24 Q4	527.12M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Concord Biotech Limited

Video analysis: CONCORDBIO.NS

News: CONCORDBIO.NS

Similar companies